These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6839956)

  • 1. Some consequences of drug choice and dosage regimen for patients with impaired kidney function.
    Vree TB; Hekster CA; van Dalen R
    Drug Intell Clin Pharm; 1983 Apr; 17(4):267-73. PubMed ID: 6839956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.
    Drayer DE
    Clin Pharmacokinet; 1976; 1(6):426-43. PubMed ID: 799549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.
    Vree TB; Hekster CA; van der Kleijn E
    Drug Intell Clin Pharm; 1982 Feb; 16(2):126-31. PubMed ID: 7075463
    [No Abstract]   [Full Text] [Related]  

  • 4. Active drug metabolites and renal failure.
    Drayer DE
    Am J Med; 1977 Apr; 62(4):486-9. PubMed ID: 851118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.
    Vree TB; Hekster YA; Damsma JE; van Dalen R; Hafkenscheid JC; Friesen WT
    Ther Drug Monit; 1981; 3(2):129-35. PubMed ID: 7268825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal failure, drug pharmacokinetics and drug action.
    Fabre J; Balant L
    Clin Pharmacokinet; 1976; 1(2):99-120. PubMed ID: 13956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An outlook on pharmacokinetics in chemotherapy.
    Otaya H
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):430-2. PubMed ID: 700916
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function.
    Rieder J; Schwartz DE; Fernex M; Bergan T; Brodwall EK; Blumberg A; Cottier P; Scheitlin W
    Antibiot Chemother (1971); 1974; 18():148-98. PubMed ID: 4463825
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics in renal disease.
    Levy G
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
    Kamath BL; Lai CM; Gupta SD; Durrani MJ; Yacobi A
    J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal disease and drug metabolism: an overview.
    Gibson TP
    Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doses and dosage intervals of drugs--clinical practice and pharmacokinetic principles.
    Boëthius G; Sjöqvist F
    Clin Pharmacol Ther; 1978 Sep; 24(3):255-63. PubMed ID: 28868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolite formation pharmacokinetics: rate and extent of metabolite formation determined by deconvolution.
    Karol MD; Goodrich S
    Pharm Res; 1988 Jun; 5(6):347-51. PubMed ID: 2469080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of procainamide and N-acetylprocainamide in renal failure.
    Gibson TP; Atkinson AJ; Matusik E; Nelson LD; Briggs WA
    Kidney Int; 1977 Dec; 12(6):422-9. PubMed ID: 609192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.
    Lee CS; Marbury TC
    Clin Pharmacokinet; 1984; 9(1):42-66. PubMed ID: 6362952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of renal excretion of drugs (with special reference to drugs used by anaesthetists).
    Prescott LF
    Br J Anaesth; 1972 Mar; 44(3):246-51. PubMed ID: 4401573
    [No Abstract]   [Full Text] [Related]  

  • 17. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide.
    Vlasses PH; Kosoglou T; Chase SL; Greenspon AJ; Lottes S; Andress E; Ferguson RK; Rocci ML
    Arch Intern Med; 1989 Jun; 149(6):1350-3. PubMed ID: 2471472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.
    Somogyi A; McLean A; Heinzow B
    Eur J Clin Pharmacol; 1983; 25(3):339-45. PubMed ID: 6194997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of sulfonamides in children: relationship between maturing kidney function and renal clearance of sulfonamides.
    Vree TB; Hekster YA; Lippens RJ
    Ther Drug Monit; 1985; 7(2):130-47. PubMed ID: 3895605
    [No Abstract]   [Full Text] [Related]  

  • 20. Some pitfalls in selecting descriptive pharmacokinetic models.
    Vree TB; Hekster YA; Oosterbaan MJ; Termond EF
    Drug Intell Clin Pharm; 1984 Sep; 18(9):708-13. PubMed ID: 6479019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.